Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response

Por Margaret Folaron, Mihai Merzianu, Umamaheswar Duvvuri, Robert L. Ferris, Mukund Seshadri
Publicado em 2019-07-01

Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients

Por Zaima Mazorra, Anabel Lavastida, Fernando Concha-Benavente, Anet Valdés, Raghvendra M. Srivastava, Tatiana M. García-Bates, Esperanza Hechavarría, Zuyen González, Amnely González, Martha Lugiollo, Iván Cuevas, Carlos Frómeta, Braulio F. Mestre, Maria C. Barroso, Tania Crombet, Robert L. Ferris, Robert L. Ferris, Robert L. Ferris
Publicado em 2017-06-01

Otolaryngology, Head and Neck Surgery

Por Tsung-Lin Yang, Robert L. Ferris, Tetsuya Ogawa, Peter Hwang, Michael Tong, Mu-Kuan Chen
Publicado em 2014-01-01

EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.

Por Wenbo Ma, Fernando Concha-Benavente, Saskia J A M Santegoets, Marij J P Welters, Ilina Ehsan, Robert L Ferris, Sjoerd H van der Burg
Publicado em 2018-01-01

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Por Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani
Publicado em 2022-04-01